Abstract BackgroundDefine the effectiveness of a topical non-steroidal anti-inflammatory drug (NSAID) added to topical steroid use after uncomplicated phacoemulsification for the prevention of pseudophakic cystoid macular edema (PCME) using a prospective, randomized, double-masked, placebo-controlled clinical study. MethodsEyes (1000) were randomized to placebo (497) or nepafenac 0.3�503) used once daily, post-operatively for 5 weeks at two ophthalmology clinics. Diagnosis of PCME was made by clinical, ocular coherence tomography (OCT), and with fluorescein angiography confirmation. Correlation of PCME to NSAID use and the presence of pre-operative risk factors for PCME were assessed including, contralateral PCME, diabetic retinopathy, retinal vein occlusion, macular hole, epiretinal membrane, macular degeneration, retinal detachment repair, and prostaglandin use. ResultsPCME was the most common complication associated with routine cataract surgery (4.2�ith PCME risk factors, 2.0�ith risk factors excluded). Topical nepafenac 0.3�ignificantly reduces the incidence of PCME compared to placebo when used after routine cataract surgery (p = .0001). When patients with pre-operative risk factors are excluded, the incidence of PCME between treatment and placebo groups is equivalent (p = 0.31). PCME relative risk (RR) was most significant in contralateral PCME (RR 19.5), diabetic retinopathy (RR 13.1), retinal vein occlusion (RR 12.9), macular hole (RR 7.7), and epiretinal membrane (RR 5.7). Prostaglandin use and previous retinal detachment were not shown to increase risk. ConclusionPseudophakic cystoid macular edema is common after phacoemulsification cataract surgery. Topical nepafenac 0.3�educes PCME in patients with pre-operative risk factors for PCME compared to placebo but shows no benefit in patients without pre-operative risk factors. Trial registrationNIH ClincalTrials.gov retrospectively registered January 15, 2017, NCT03025945.
placebo             0.9999999999483862^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

cataract surgery              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cataract_surgery      

NSAID                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Non-steroidal_anti-inflammatory_drug

macular hole                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_hole          

ophthalmology                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Ophthalmology         

Prostaglandin                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Prostaglandin         

relative risk                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Relative_risk         

incidence                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Incidence_(epidemiology)

macular degeneration          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_degeneration  

diabetic retinopathy          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diabetic_retinopathy  

RR                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Relative_risk         

RR                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Relative_risk         

coherence                     0.9999256277521702^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Coherence_(physics)   

retinal detachment            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retinal_detachment    

cataract surgery              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cataract_surgery      

retinal vein occlusion        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Central_retinal_vein_occlusion

macular hole                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_hole          

non-steroidal anti-inflammatory drug1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Non-steroidal_anti-inflammatory_drug

phacoemulsification           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phacoemulsification   

contralateral                 0.9999999957465207^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Anatomical_terms_of_location

phacoemulsification           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phacoemulsification   

risk factors                  0.7662351144687228^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Stroke                

pseudophakic                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Intraocular_lens      

placebo-controlled            0.9999998979310528^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

risk factors                  0.7662351144687228^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Stroke                

RR                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Relative_risk         

RR                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Relative_risk         

tomography                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/X-ray_computed_tomography

cataract surgery              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cataract_surgery      

OCT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Optical_coherence_tomography

risk factors                  0.7662351144687228^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Stroke                

retinal vein occlusion        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Central_retinal_vein_occlusion

placebo                       0.9999999999483862^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

clinical study                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Clinical_trial        

topical steroid               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Topical_steroid       

placebo                       0.9999999999483862^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

placebo                       0.9999999999483862^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

risk factors                  0.7662351144687228^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Stroke                

incidence                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Incidence_(epidemiology)

cystoid macular edema         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_edema         

RR                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Relative_risk         

ocular                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Human_eye             

risk factors                  0.7662351144687228^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Stroke                

NSAID                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Non-steroidal_anti-inflammatory_drug

cystoid macular edema         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_edema         

diabetic retinopathy          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diabetic_retinopathy  

retinal detachment            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retinal_detachment    

prostaglandin                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Prostaglandin         

epiretinal membrane           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Epiretinal_membrane   

contralateral                 0.9999999957465207^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Anatomical_terms_of_location

epiretinal membrane           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Epiretinal_membrane   

risk factors                  0.7662351144687228^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Stroke                

fluorescein angiography       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Fluorescein_angiography

RR                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Relative_risk         

